203 related articles for article (PubMed ID: 29538258)
1. A Randomized Phase 2 Study of ADXS11-001 Listeria monocytogenes-Listeriolysin O Immunotherapy With or Without Cisplatin in Treatment of Advanced Cervical Cancer.
Basu P; Mehta A; Jain M; Gupta S; Nagarkar RV; John S; Petit R
Int J Gynecol Cancer; 2018 May; 28(4):764-772. PubMed ID: 29538258
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group study.
Huh WK; Brady WE; Fracasso PM; Dizon DS; Powell MA; Monk BJ; Leath CA; Landrum LM; Tanner EJ; Crane EK; Ueda S; McHale MT; Aghajanian C
Gynecol Oncol; 2020 Sep; 158(3):562-569. PubMed ID: 32641240
[TBL] [Abstract][Full Text] [Related]
3. A phase II study of axalimogene filolisbac for patients with previously treated, unresectable, persistent/recurrent loco-regional or metastatic anal cancer.
Eng C; Fakih M; Amin M; Morris V; Hochster HS; Boland PM; Uronis H
Oncotarget; 2020 Apr; 11(15):1334-1343. PubMed ID: 32341753
[TBL] [Abstract][Full Text] [Related]
4. ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer.
Galicia-Carmona T; Arango-Bravo E; Serrano-Olvera JA; Flores-de La Torre C; Cruz-Esquivel I; Villalobos-Valencia R; Morán-Mendoza A; Castro-Eguiluz D; Cetina-Pérez L
Hum Vaccin Immunother; 2021 Aug; 17(8):2617-2625. PubMed ID: 33793380
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic options for treatment of human papillomavirus-associated cancers - novel immunologic vaccines: ADXS11-001.
Miles B; Safran HP; Monk BJ
Gynecol Oncol Res Pract; 2017; 4():10. PubMed ID: 28725449
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic insights into ADXS11-001 human papillomavirus-associated cancer immunotherapy.
Miles BA; Monk BJ; Safran HP
Gynecol Oncol Res Pract; 2017; 4():9. PubMed ID: 28588899
[TBL] [Abstract][Full Text] [Related]
7. Tolerability of ADXS11-001 Lm-LLO Listeria-Based Immunotherapy With Mitomycin, Fluorouracil, and Radiation for Anal Cancer.
Safran H; Leonard KL; Perez K; Vrees M; Klipfel A; Schechter S; Oldenburg N; Roth L; Shah N; Rosati K; Rajdev L; Mantripragada K; Sheng IY; Barth P; DiPetrillo TA
Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1175-1178. PubMed ID: 29722659
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors from a randomized phase III trial of paclitaxel and carboplatin versus paclitaxel and cisplatin in metastatic or recurrent cervical cancer: Japan Clinical Oncology Group (JCOG) trial: JCOG0505-S1.
Nishio S; Kitagawa R; Shibata T; Yoshikawa H; Konishi I; Ushijima K; Kamura T
Cancer Chemother Pharmacol; 2016 Oct; 78(4):785-90. PubMed ID: 27553435
[TBL] [Abstract][Full Text] [Related]
9. Results of concurrent chemotherapy and hyperthermia in patients with recurrent cervical cancer after previous chemoradiation.
Heijkoop ST; van Doorn HC; Stalpers LJ; Boere IA; van der Velden J; Franckena M; Westermann AM
Int J Hyperthermia; 2014 Feb; 30(1):6-10. PubMed ID: 24156619
[TBL] [Abstract][Full Text] [Related]
10. Californium-252 neutron brachytherapy combined with external pelvic radiotherapy plus concurrent chemotherapy for cervical cancer: a retrospective clinical study.
Qian S; Ye L; Tian YH; Wang LG; Huang ZP; Li F; Hou B; Song N; Chen J; Liu Y; Liu X; Zhou T
Chin J Cancer; 2017 Feb; 36(1):24. PubMed ID: 28245859
[TBL] [Abstract][Full Text] [Related]
11. Outcomes and toxicities for the treatment of stage IVB cervical cancer.
Hwang JH; Lim MC; Seo SS; Kang S; Park SY; Kim JY
Arch Gynecol Obstet; 2012 Jun; 285(6):1685-93. PubMed ID: 22173823
[TBL] [Abstract][Full Text] [Related]
12. Cervical non-squamous carcinoma: an effective combination chemotherapy of taxane, anthracycline and platinum for advanced or recurrent cases.
Kimura T; Miyatake T; Ueda Y; Ohta Y; Enomoto T; Kimura T; Kamiura S
Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):200-4. PubMed ID: 22770633
[TBL] [Abstract][Full Text] [Related]
13. Carboplatin-based chemoradiotherapy in advanced cervical cancer: an alternative to cisplatin-based regimen?
Sebastião AM; da Silva Rocha LS; Gimenez RD; de Barros LA; Fukushima JT; da Silva SC; da Costa Miranda V; de Souza Caires IQ; de Freitas D; Filho EA; Diz Mdel P
Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():161-5. PubMed ID: 27137353
[TBL] [Abstract][Full Text] [Related]
14. RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma.
Schefter T; Winter K; Kwon JS; Stuhr K; Balaraj K; Yaremko BP; Small W; Sause W; Gaffney D;
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):101-5. PubMed ID: 24331655
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant properties of listeriolysin O protein in a DNA vaccination strategy.
Peng X; Treml J; Paterson Y
Cancer Immunol Immunother; 2007 Jun; 56(6):797-806. PubMed ID: 17102978
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix.
Fiorica J; Holloway R; Ndubisi B; Orr J; Grendys E; Boothby R; DeCesare S; LaPolla J; Hoffman M; Patel J
Gynecol Oncol; 2002 Apr; 85(1):89-94. PubMed ID: 11925125
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of concurrent weekly carboplatin with radiotherapy in the treatment of cervical cancer: A meta-analysis.
Xue R; Cai X; Xu H; Wu S; Huang H
Gynecol Oncol; 2018 Sep; 150(3):412-419. PubMed ID: 29996970
[TBL] [Abstract][Full Text] [Related]
18. Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: final results of a randomized, double-blind, placebo-controlled, phase 3 study.
Urba S; van Herpen CM; Sahoo TP; Shin DM; Licitra L; Mezei K; Reuter C; Hitt R; Russo F; Chang SC; Hossain AM; Frimodt-Moller B; Koustenis A; Hong RL
Cancer; 2012 Oct; 118(19):4694-705. PubMed ID: 22434360
[TBL] [Abstract][Full Text] [Related]
19. Combined chemoradiation of cisplatin versus carboplatin in cervical carcinoma: a single institution experience from Thailand.
Tharavichitkul E; Lorvidhaya V; Kamnerdsupaphon P; Sukthomya V; Chakrabandhu S; Klunklin P; Onchan W; Supawongwattana B; Pukanhaphan N; Galalae R; Chitapanarux I
BMC Cancer; 2016 Jul; 16():501. PubMed ID: 27435245
[TBL] [Abstract][Full Text] [Related]
20. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Rose PG; Bundy BN; Watkins EB; Thigpen JT; Deppe G; Maiman MA; Clarke-Pearson DL; Insalaco S
N Engl J Med; 1999 Apr; 340(15):1144-53. PubMed ID: 10202165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
